Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

• Status: Completed
• Trial end date: 2013-11-30
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess the safety, tolerability, and pharmacokinetics (PK) of orally administered ALS-008176 in healthy volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Alios Biopharma Inc.

Criteria

Inclusion Criteria:

• Male or female subjects, 18-55 years of age, in good health with screening laboratory values within limits specified by the protocol

• Body mass index 18-30 kg/m2

• Female subjects must be of non-childbearing potential; male subjects must be surgically sterile or practicing birth control

Exclusion Criteria:

• Clinically significant or uncontrolled medical illness

• Use, or anticipated use during conduct of the study, of concomitant medications